UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glypican-3 antibodies: A new therapeutic target for liver cancer

FEBS letters, 2014-01, Vol.588 (2), p.377-382

2014

Volltextzugriff (PDF)

MitoQ Protects Ovarian Organoids against Oxidative Stress during Oogenesis and Folliculogenesis In Vitro

International journal of molecular sciences, 2023-01, Vol.24 (2), p.924

2023

Volltextzugriff (PDF)

A novel LAG3 neutralizing antibody improves cancer immunotherapy by dual inhibition of MHC-II and FGL1 ligand binding

Biomedicine & pharmacotherapy, 2024-06, Vol.175, p.116782, Article 116782

2024

Volltextzugriff (PDF)

EGFRvⅢ-targeted immunotoxin combined with temozolomide and bispecific antibody for the eradication of established glioblastoma

Biomedicine & pharmacotherapy, 2022-11, Vol.155, p.113659-113659, Article 113659

2022

Volltextzugriff (PDF)

Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects

Pharmacological research, 2024-05, Vol.203, p.107186-107186, Article 107186

2024

Volltextzugriff (PDF)

BMPQ-1 binds selectively to (3+1) hybrid topologies in human telomeric G-quadruplex multimers

Nucleic acids research, 2020-11, Vol.48 (20), p.11259-11269

2020

Volltextzugriff (PDF)

Inhibition of EED activity enhances cell survival of female germline stem cell and improves the oocytes production during oogenesis in vitro

Open biology, 2023-01, Vol.13 (1), p.220211-220211

2023

Volltextzugriff (PDF)

Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody

Biomedicine & pharmacotherapy, 2023-07, Vol.163, p.114797-114797, Article 114797

2023

Volltextzugriff (PDF)

Glypican‑3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy

Molecular pharmaceutics, 2015-06, Vol.12 (6), p.2151-2157

2015

Volltextzugriff (PDF)

A global view of altered ligand-receptor interactions in bone marrow aging based on single-cell sequencing

Computational and structural biotechnology journal, 2024-12, Vol.23, p.2754-2762

2024

Volltextzugriff (PDF)

A novel high‐affinity human monoclonal antibody to mesothelin

International journal of cancer, 2011-05, Vol.128 (9), p.2020-2030

2011

Volltextzugriff (PDF)

Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers

Frontiers in bioscience (Landmark. Print), 2024-05, Vol.29 (5), p.182-182

2024

Volltextzugriff (PDF)

The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy

PloS one, 2011-01, Vol.6 (1), p.e14640

2011

Volltextzugriff (PDF)

Mesothelin as a potential therapeutic target in human cholangiocarcinoma

Journal of Cancer, 2010-01, Vol.1 (1), p.141-149

2010

Volltextzugriff (PDF)

Utilization of carbon-based energy as raw material instead of fuel with low CO2 emissions: Energy analyses and process integration of chemical looping ammonia generation

Applied energy, 2022-04, Vol.312, p.118809, Article 118809

2022

Volltextzugriff (PDF)

In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice

Journal of Cancer, 2011-01, Vol.2 (1), p.123-131

2011

Volltextzugriff (PDF)

Using Coal Coke for N‑Sorption with an Al-based Nitrogen Carrier during Chemical Looping Ammonia Generation

Energy & fuels, 2020-10, Vol.34 (10), p.12527-12534

2020

Volltextzugriff (PDF)

Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy

Oncotarget, 2017-05, Vol.8 (20), p.32450-32460

2017

Volltextzugriff (PDF)

A Frizzled‐Like Cysteine‐Rich Domain in Glypican‐3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice

Hepatology (Baltimore, Md.), 2019-10, Vol.70 (4), p.1231-1245

2019

Volltextzugriff (PDF)

Identification of nurse shark VNAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV‐2

The FASEB journal, 2023-06, Vol.37 (6), p.e22973-n/a

2023

Volltextzugriff (PDF)

Angptl7 promotes insulin resistance and type 2 diabetes mellitus by multiple mechanisms including SOCS3‐mediated IRS1 degradation

The FASEB journal, 2020-10, Vol.34 (10), p.13548-13560

2020

Volltextzugriff (PDF)

Tn5 transposase-assisted high-efficiency transformation of filamentous fungus Phoma herbarum YS4108

Applied microbiology and biotechnology, 2008-10, Vol.80 (5), p.937-944

2008

Volltextzugriff (PDF)

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican‐3 for liver cancer therapy

Hepatology (Baltimore, Md.), 2014-08, Vol.60 (2), p.576-587

2014

Volltextzugriff (PDF)

Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis

Nature communications, 2015-03, Vol.6 (1), p.6536-6536, Article 6536

2015

Volltextzugriff (PDF)

Mesothelin-targeted CAR-T therapy combined with irinotecan for the treatment of solid cancer

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (16), p.15027-15038

2023

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

ThemaProteins

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(51)
Animals
(24)
Humans
(24)
Technology
(24)
Mice
(19)
Physical Sciences
(19)
Female
(15)
Biochemistry & Molecular Biology
(13)
Chemistry
(13)
Engineering
(11)
Oncology
(11)
Materials Science
(10)
Science & Technology - Other Topics
(10)
Cell Line, Tumor
(8)
Liver Neoplasms - Pathology
(8)
Materials Science, Multidisciplinary
(8)
Xenograft Model Antitumor Assays
(8)
Cell Biology
(7)
Pharmacology & Pharmacy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Glypican-3 antibodies: A new therapeutic target for liver cancer

MitoQ Protects Ovarian Organoids against Oxidative Stress during Oogenesis and Folliculogenesis In Vitro

A novel LAG3 neutralizing antibody improves cancer immunotherapy by dual inhibition of MHC-II and FGL1 ligand binding

EGFRvⅢ-targeted immunotoxin combined with temozolomide and bispecific antibody for the eradication of established glioblastoma

Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects

BMPQ-1 binds selectively to (3+1) hybrid topologies in human telomeric G-quadruplex multimers

Inhibition of EED activity enhances cell survival of female germline stem cell and improves the oocytes production during oogenesis in vitro

Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody

Glypican‑3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy

A global view of altered ligand-receptor interactions in bone marrow aging based on single-cell sequencing

A novel high‐affinity human monoclonal antibody to mesothelin

Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers

The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy

Mesothelin as a potential therapeutic target in human cholangiocarcinoma

Utilization of carbon-based energy as raw material instead of fuel with low CO2 emissions: Energy analyses and process integration of chemical looping ammonia generation

In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice

Using Coal Coke for N‑Sorption with an Al-based Nitrogen Carrier during Chemical Looping Ammonia Generation

Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy

A Frizzled‐Like Cysteine‐Rich Domain in Glypican‐3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice

Identification of nurse shark VNAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV‐2

Angptl7 promotes insulin resistance and type 2 diabetes mellitus by multiple mechanisms including SOCS3‐mediated IRS1 degradation

Tn5 transposase-assisted high-efficiency transformation of filamentous fungus Phoma herbarum YS4108

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican‐3 for liver cancer therapy

Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis

Mesothelin-targeted CAR-T therapy combined with irinotecan for the treatment of solid cancer

Aktive Filter

Suchergebnisse filtern